Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amylyx Pharmaceuticals, Inc. (AMLX)
:AMLX
RESEARCH TOOLSreports
Holding AMLX?
Track your performance easily
Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview
13.86% Insiders
4.92% Mutual Funds
0.13% Other Institutional Investors
5.21% ETFs
75.88% Public Companies and Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 10.26% of the company’s stock is owned by Institutional Investors, 13.86% is owned by Insiders, and 75.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 08, 2025 | Justin B. Klee Co Ceo,director | xxxxxxxxxxxxx | $30183 |
| Jan 08, 2025 | Joshua B Cohen Co Ceo,director | xxxxxxxxxxxxx | $30183 |
| Dec 03, 2024 | Camille Bedrosian Director | xxxxxxxxxxxxx | $29978 |
| Oct 02, 2024 | Justin B. Klee Co Ceo,director | xxxxxxxxxxxxx | $59299 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $220177 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $2169137 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $6887102 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,202,381 | Insider | 4.70% | 10,792,024 | |
| 3,213,098 | Insider | 3.75% | 10,828,140 | |
| 3,176,788 | Insider | 3.71% | 10,705,776 | |
| 2,411,538 | Institution | 2.81% | 8,126,883 | |
| 2,355,194 | Institution | 2.75% | 7,937,004 | |
| 2,125,649 | Institution | 2.48% | 7,163,437 | |
| 1,150,221 | Institution | 1.34% | 3,876,245 | |
| 936,967 | Institution | 1.09% | 3,157,579 | |
| 858,571 | Insider | 1.00% | 2,893,384 | |
| 778,900 | Institution | 0.91% | 2,624,893 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,411,538 | Institution | 2.81% | 8,126,883 | |
| 384,510 | Institution | 0.45% | 1,295,799 | |
| 353,447 | Institution | 0.41% | 1,191,116 | |
| 348,375 | Institution | 0.41% | 1,174,024 | |
| 157,412 | Institution | 0.18% | 530,478 | |
| 147,666 | Institution | 0.17% | 497,634 | |
| 130,000 | Institution | 0.15% | 438,100 | |
| 65,400 | Institution | 0.08% | 220,398 | |
| 38,707 | Institution | 0.05% | 130,443 | |
| 33,909 | Institution | 0.04% | 114,273 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,482,532 | Institution | 1.73% | 8,213,227 | |
| 727,341 | Institution | 0.85% | 4,029,469 | |
| 387,802 | Institution | 0.45% | 1,179,095 | |
| 285,616 | Institution | 0.33% | 962,526 | |
| 277,827 | Institution | 0.32% | 936,277 | |
| 249,355 | Institution | 0.29% | 780,481 | |
| 183,055 | Institution | 0.21% | 572,962 | |
| 183,055 | Institution | 0.21% | 572,962 | |
| 145,321 | Institution | 0.17% | 805,078 | |
| 144,927 | Institution | 0.17% | 488,404 |
FAQ
Who Owns Amylyx Pharmaceuticals, Inc. (AMLX)?
According to the latest TipRanks data, approximately 0.13% of the company's stock is held by institutional investors, 13.86% is held by insiders, and 75.88% is held by retail investors.
What percentage of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.13% of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by institutional investors.
What percentage of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.88% of Amylyx Pharmaceuticals, Inc. (AMLX) stock is held by retail investors.
Who owns the most shares of Amylyx Pharmaceuticals, Inc. (AMLX)?
Steven A. Cohen owns the most shares of Amylyx Pharmaceuticals, Inc. (AMLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.